ETFs With Bristol-Myers Squibb Company (BMY) Exposure

The following ETFs maintain significant exposure to Bristol-Myers Squibb Company (BMY); each of the following funds counts BMY among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.

To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.

Ticker ETF ETFdb Category Expense Ratio Weighting
IHE iShares U.S. Pharmaceuticals ETF Health & Biotech Equities 0.46% 6.04%
PJP Dynamic Pharmaceuticals Health & Biotech Equities 0.63% 5.00%
PPH Market Vectors Pharmaceutical ETF Health & Biotech Equities 0.35% 4.46%
XLV Health Care Select Sector SPDR Health & Biotech Equities 0.16% 3.48%
PWB Dynamic LargeCap Growth Large Cap Growth Equities 0.59% 3.38%
IYH iShares U.S. Healthcare ETF Health & Biotech Equities 0.46% 3.24%
GVT Select Large Cap Value ETF Large Cap Value Equities 0.79% 3.24%
FHLC MSCI Health Care Index ETF Health & Biotech Equities 0.12% 2.90%
VHT Health Care ETF Health & Biotech Equities 0.14% 2.89%
QINC RBA Quality Income ETF All Cap Equities 0.70% 2.18%


© 2014 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Enter a ticker symbol or keyword: